Older patients (especially those over 60) and those with preexisting cardiovascular disease benefit from lower GLP-1 starting doses, slower titration, and more frequent monitoring
Understanding retatrutide's mechanism of action helps clarify why combining it with other metabolically active substances requires careful thought
10 That is to say, if autism is indeed an ancient and natural consequence of being human, then autism may be much more difficult to prevent than if it is induced by factors present in modern society
In April 2025, AstraZeneca Plc could receive European Medicines Agency (EMA) approval for ECC5004, its oral GLP-1RA, for the treatment of obesity, intensifying competition in the oral treatment segment
Understanding how these medications work provides important context for recognizing and managing potential side effects, including fatigue